Enova International, Inc. vs NELNET, INC., two Credit Services stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Reported margins mislead at both (Nelnet's 111.7% net margin is an investment-gain artifact), so returns carry the pair: Enova earns 23.3% on equity against Nelnet's 11.2%, the focused online consumer lender doubling the diversified student-loan servicer-investor. Enova trades at 18.8 times earnings against Nelnet's 11.7, the growth-lender premium against the lumpy-holding discount. Both carry heavy leverage, 3.45 and 2.06 turns, and pay small dividends. Enova's 30.5% free-cash figure and Nelnet's 7.6% are both loan-and-investment-flavored. Enova earns twice the return on equity and trades at seven turns more multiple, the market paying for both the returns and the growth.
Comparison updated 2026-07-11.
| Metric | ENVA | NNI |
|---|---|---|
| Price | $230.90 | $134.48 |
| Market cap | $6.1B | $4.9B |
| Sector | Financial Services | Financial Services |
| Stage | Growth | Growth |
| Implied growth (priced in) | +1.2% | +16.4% |
| P/E | 18.8 | 11.7 |
| P/B | 4.34 | 1.30 |
| P/S | 1.85 | 12.99 |
| EV/EBITDA | 13.3 | 138.8 |
| Revenue growth | +17.6% | +23.6% |
| Gross margin | 60.4% | — |
| Operating margin | 23.7% | — |
| Net margin | 9.9% | 111.7% |
| Return on equity | 23.3% | 11.2% |
| Return on assets | 4.8% | 2.9% |
| Dividend yield | 1.6% | 0.4% |
| Debt / equity | 3.45 | 2.06 |
| Altman Z (solvency) | 1.67 | 0.67 |
| Piotroski F (quality) | 7 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.